CALM: Managing Distress in Malignant Brain Cancer
Virginia Commonwealth University
Virginia Commonwealth University
Mayo Clinic
Washington University School of Medicine
Incyte Corporation
Thomas Jefferson University
National Institutes of Health Clinical Center (CC)
Revolution Medicines, Inc.
Arbeitsgemeinschaft medikamentoese Tumortherapie
Labcorp Corporation of America Holdings, Inc
Inova Health Care Services
Cedars-Sinai Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Bristol-Myers Squibb
University of Southern California
Cedars-Sinai Medical Center
Memorial Sloan Kettering Cancer Center
Celldex Therapeutics
University of California, San Francisco
NextCure, Inc.
National Cancer Institute (NCI)
Apexigen America, Inc.
Yale University
Klus Pharma Inc.
Cantargia AB
Revolution Medicines, Inc.
Eastern Cooperative Oncology Group
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Prelude Therapeutics
Quadriga Biosciences, Inc.
Roswell Park Cancer Institute
Peter MacCallum Cancer Centre, Australia
Pfizer
Incyte Corporation
Incyte Corporation
Rutgers, The State University of New Jersey
BioNTech SE
DEKK-TEC, Inc.
Asana BioSciences
Celgene
Memorial Sloan Kettering Cancer Center
University of Wisconsin, Madison
AstraZeneca
Icahn School of Medicine at Mount Sinai
British Columbia Cancer Agency
Stanford University
University of Texas Southwestern Medical Center
Cancer Trials Ireland
Novartis